Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Encoberminogene Rezmadenovec

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exelixis Announces Q3 2024 Financial Results and Update
    Exelixis Announces Q3 2024 Financial Results and Update

    29 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241029473805/en

    BUSINESSWIRE
    29 Oct 2024
    Share Share
    Exelixis Announces Initiation of the STELLAR-305 Phase 2/3 Pivotal Trial
    Exelixis Announces Initiation of the STELLAR-305 Phase 2/3 Pivotal Trial

    04 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231201184887/en

    BUSINESSWIRE
    04 Dec 2023
    Share Share
    Exelixis and Arcus Announce Trial Collaboration to Evaluate Zanzalintinib
    Exelixis and Arcus Announce Trial Collaboration to Evaluate Zanzalintinib

    04 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231203437225/en

    BUSINESSWIRE
    04 Dec 2023
    Share Share
    Exelixis Announces Results from Expansion Cohort of Phase 1b STELLAR-001 Trial
    Exelixis Announces Results from Expansion Cohort of Phase 1b STELLAR-001 Trial

    10 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231106261142/en

    BUSINESSWIRE
    10 Nov 2023
    Share Share